TY - JOUR
T1 - International experts’ practice in the antibiotic therapy of infective endocarditis is not following the guidelines
AU - Tissot-Dupont, H.
AU - Casalta, J. P.
AU - Gouriet, F.
AU - Hubert, S.
AU - Salaun, E.
AU - Habib, G.
AU - Fernandez-Gerlinger, M. P.
AU - Mainardi, J. L.
AU - Tattevin, P.
AU - Revest, M.
AU - Lucht, F.
AU - Botelho-Nevers, E.
AU - Gagneux-Brunon, A.
AU - Snygg-Martin, U.
AU - Chan, K. L.
AU - Bishara, J.
AU - Vilacosta, I.
AU - Olmos, C.
AU - San Román, J. A.
AU - López, J.
AU - Tornos, P.
AU - Fernández-Hidalgo, N.
AU - Durante-Mangoni, E.
AU - Utili, R.
AU - Paul, M.
AU - Baddour, L. M.
AU - DeSimone, D. C.
AU - Sohail, M. R.
AU - Steckelberg, J. M.
AU - Wilson, W. R.
AU - Raoult, D.
N1 - Publisher Copyright:
© 2017 European Society of Clinical Microbiology and Infectious Diseases
PY - 2017/10
Y1 - 2017/10
N2 - Objective The management of infective endocarditis (IE) may differ from international guidelines, even in reference centres. This is probably because most recommendations are not based on hard evidence, so the consensus obtained for the guidelines does not represent actual practices. For this reason, we aimed to evaluate this question in the particular field of antibiotic therapy. Methods Thirteen international centres specialized in the management of IE were selected, according to their reputation, clinical results, original research publications and quotations. They were asked to detail their actual practice in terms of IE antibiotic treatment in various bacteriological and clinical situations. They were also asked to declare their IE-related in-hospital mortality for the year 2015. Results The global compliance with guidelines concerning antibiotic therapy was 58%, revealing the differences between theoretical ‘consensus’, local recommendations and actual practice. Some conflicts of interest were also probably expressed. The adherence to guidelines was 100% when the protocol was simple, and decreased with the seriousness of the situation (Staphylococus spp. 54%–62%) or in blood-culture-negative endocarditis (0%–15%) that requires adaptation to clinical and epidemiological data. Conclusion Worldwide experts in IE management, although the majority of them were involved and co-signed the guidelines, do not follow international consensus guidelines on the particular point of the use of antibiotics.
AB - Objective The management of infective endocarditis (IE) may differ from international guidelines, even in reference centres. This is probably because most recommendations are not based on hard evidence, so the consensus obtained for the guidelines does not represent actual practices. For this reason, we aimed to evaluate this question in the particular field of antibiotic therapy. Methods Thirteen international centres specialized in the management of IE were selected, according to their reputation, clinical results, original research publications and quotations. They were asked to detail their actual practice in terms of IE antibiotic treatment in various bacteriological and clinical situations. They were also asked to declare their IE-related in-hospital mortality for the year 2015. Results The global compliance with guidelines concerning antibiotic therapy was 58%, revealing the differences between theoretical ‘consensus’, local recommendations and actual practice. Some conflicts of interest were also probably expressed. The adherence to guidelines was 100% when the protocol was simple, and decreased with the seriousness of the situation (Staphylococus spp. 54%–62%) or in blood-culture-negative endocarditis (0%–15%) that requires adaptation to clinical and epidemiological data. Conclusion Worldwide experts in IE management, although the majority of them were involved and co-signed the guidelines, do not follow international consensus guidelines on the particular point of the use of antibiotics.
KW - Blood culture negative endocarditis
KW - Endocarditis Treatment
KW - Experts
KW - Guidelines and practice
KW - Staphylococcus aureus endocarditis
UR - http://www.scopus.com/inward/record.url?scp=85018663335&partnerID=8YFLogxK
U2 - 10.1016/j.cmi.2017.03.007
DO - 10.1016/j.cmi.2017.03.007
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 28323194
AN - SCOPUS:85018663335
SN - 1198-743X
VL - 23
SP - 736
EP - 739
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
IS - 10
ER -